T 0518/22 (Type-A DNA polymerase mutants/AGILENT) of 30.10.2024

European Case Law Identifier: ECLI:EP:BA:2024:T051822.20241030
Date of decision: 30 October 2024
Case number: T 0518/22
Petition for review of: -
Application number: 10805180.6
IPC class: C07K 14/00 C12N 9/12 C12N 15/00 G01N 33/00 C12Q 1/68 C12N 15/10 C12N 15/54 C12N 15/11
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: Abstract on Article 123(2) EPC
Application title: Thermostable Type-A DNA polymerase mutants with increased polymerization rate and resistance to inhibitors
Applicant name: Agilent Technologies, Inc.
Opponent name: Roche Diagnostics GmbH
Board: 3.3.08
Headnote: -
Relevant legal provisions: European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54 European Patent Convention Art 56 European Patent Convention Art 83 European Patent Convention Art 84 European Patent Convention Art 87Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
Keywords: Main request and auxiliary request 2 - added subject-matter - (yes)
Undisclosed disclaimer - not allowable
Auxiliary request 1 - novelty - (no)
Auxiliary request 3 - requirements of the EPC met - (yes)
Catchword: -
Cited cases: G 0001/03 G 0003/14 G 0001/15 G 0001/16 G 0002/21 G 0001/22 G 0002/22 T 0032/84 T 0292/85 T 2790/17 T 0521/18 T 1975/19 T 0025/20 T 0559/20 T 2164/21
Citing cases: -

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the opposition division with the

order to maintain the patent on the basis of the claims of

auxiliary request 3, filed as auxiliary request 5 with the

statement of grounds of appeal, drawings: figures 1 to 10D

of the specification and a description to be adapted

thereto, if needed.